ST. LOUIS, June 30 /PRNewswire-FirstCall/ -- Sigma, a division of Sigma-Aldrich Corporation , a $1.4 billion Life Science and High Technology Company, has launched a new kit for the fluorescent quantification of proteins, FluoroProfile(TM) (FP0010) through an exclusive licensing agreement with the Australian company Fluorotechnics Pty Ltd. The technology is based on the novel fluorophore epicocconone identified by researchers at Fluorotechnics. This new approach to fluorescent quantification offers several advantages including: reversible covalent binding, large dynamic range, superior sensitivity, and exceptional emission stability. These improved performance characteristics are the result of extensive research by a team of scientists that developed the current kit employing this novel fluorophore in a convenient kit format.
The ability to bind to free amines reversibly in an aqueous environment make this the preferred method for quantification prior to mass spectrometry of precious small samples. Tolerance of buffering and solubilizing substances that interfere with other commonly used quantification methods eliminates the requirement of precipitation and risk of sample modification. Additionally, this quantification kit fits well into the integrated proteomics workflow offering from Sigma-Aldrich.
“Sigma has served the needs of scientists by providing a comprehensive offering of quantification reagents and kits to enable their research. Sigma continues to offer products that embody superior performance through internal development, continuous quality improvement and strategic collaborations. This new quantification kit launch indicates Sigma’s impressive capabilities and resources to take best-in-class products to a new level,” said George Lipscomb, Product Manager, Proteomics at Sigma-Aldrich Corporation.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. The Company’s biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. It has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 35 countries and has over 6,800 employees providing excellent service worldwide. The Company is committed to the success of its Customers, Employees and Shareholders through leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning website at http://sigma-aldrich.com .
About Fluorotechnics Pty Limited: Fluorotechnics is a Sydney-based biotechnology company formed in 2002 that develops and manufactures fluorescent compounds and fluorescence based detection kits for the global biotechnology industry. These fluorescent compounds and kits are based on Fluorotechnics owned intellectual property. Fluorotechnics acknowledges the financial assistance of the Australian and NSW Governments in the development of this product, through the R&D Start and Biotechnology Innovation Grant Schemes.
This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Company’s expectations, goals, beliefs, intentions and the like, which involve assumptions regarding Company operations and conditions in the markets the Company serves. The Company does not undertake any obligation to update these forward-looking statements.
Photo: http://www.newscom.com/cgi-bin/prnh/20050215/CGSIGMAALLOGOAP Archive: http://photoarchive.ap.orgSigma-Aldrich Corporation
CONTACT: Joan Suda, +1-314-286-7626, or George Lipscomb, +1-314-771-5765ext. 2292, both for Sigma-Aldrich Corporation
Web site: http://www.sigma-aldrich.com/
